Match Document Document Title
6162463 Extended release formulation of diltiazem hydrochloride  
An extended release formulation of diltiazem which is suitable for once-daily oral administration comprises a quantity of a quick release preparation of diltiazem or a pharmaceutically active salt...
6159501 Modified release multiple-units dosage composition for release of opioid compounds  
6156346 Urease-responsive delivery systems for diagnostic and therapeutic applications  
A delivery system that releases a diagnostic marker or therapeutic agent in a manner sensitive to the concentration of urease in a physiological compartment, particularly the gastrointestinal...
6156347 Controlled release chromium picolinate  
The present invention relates to controlled/extended release oral dosage forms of chromium picolinate. Chromium picolinate is a common and effective biologically active form of chromium. As such,...
6153218 Biphasic capsule formulation  
Capsule formulations are provided containing at least two different fill compositions which are prevented from mixing either by providing both of the fill compositions as solids or by providing a...
6132767 Administering osmotic colonic evacuant containing a picosulfate  
Colonic evacuation, treatment of small bowel bacterial overgrowth or irritable bowel syndrome or treating acute or chronic bacterial bowel infection comprises administering an osmotic colonic...
6126967 Extended release acetaminophen particles  
An extended release acetaminophen composition comprises a plurality of discrete particles containing acetaminophen which, when contained within a gelatin capsule and assayed in a USP Apparatus I...
6126767 Method of manufacturing caplets with a gelatin cover  
Disclosed is a novel simulated capsule medicament consisting of a solid core covered with two shrink-wrapped, hard-shell gelatin capsule halves. The solid cores are covered with the hard-shell...
6103260 Simethicone/anhydrous calcium phosphate compositions  
The invention relates to antifoam oral solid dosage form preparations formed from a free flowing granular composition comprising an admixture of simethicone and either one or both of granular...
6099858 Methods for preparing gelatin capsules containing fragrances  
Methods for preparing soft gelatin capsules containing fragrances are disclosed. The desired fragrance is dissolved in a solvent system comprising a volatile solvent, a non-volatile cosolvent, or a...
6090389 Method and preparations for the treatment of fungus  
A method and preparations for the treatment of vaginal yeast and other yeast infections is provided for the treatment of infections caused by Candida albicans and Cryptococcus neoformans. The...
6086915 Compositions and methods of adjusting steroid hormone metabolism through phytochemicals  
The present invention relates to spray dried hydrophobic phytochemical chemopreventative compositions, a process for making such compositions and a method of using such compositions to adjust...
6086910 Food supplements  
Disclosed is a flavonol-containing dry composition suitable for human consumption, together with uses thereof.
6086914 Nonsedating formulations for allergic rhinitis which possess antihistaminic and anticholinergic activity  
It is perceived that the newer antihistamines, which have been developed so as to be less sedating relative to the "first generation" antihistamines, possess diminished anticholinergic effects on...
6080418 Suspensions of microcapsules containing biologically active ingredients and adhesive microspheres  
A composition comprising two suspensions: A) an aqueous suspension of microcapsules containing biologically active materials and B) an adhesive suspension of adhesive microspheres. The composition...
6080426 Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process  
A process for encapsulation of caplets in a capsule comprises the following steps: a. providing empty capsule parts; b. filling at least one of said capsule parts with one or more caplets; c....
6077513 Drug for treatment of bilharziasis (Schistosomiasis)  
The method of extracting volatile oils from Commiphora molmol includes the steps of grinding up the Commiphora molmol plant; covering the ground up plant with a layer of water to create a mixture...
6077544 Spheroids, preparation process and pharmaceutical compositions  
The present invention relates to a novel pharmaceutical form, in the form of spheroids, containing one or more active principles, which the exception of tiagabine. The invention also covers the...
6071536 Gelatin capsule having adjusted water activity  
6068854 Sol-controlled thermocolloid matrix based on gelatin for oral sustained-release form  
A peroral depot medicament with controlled active substance release is composed of a gelatine matrix that continuously dissolves in an aqueous medium above 37° C., and a medicament distributed...
6066332 Immediate-effect ibuprofen-containing medicament and its use  
6063762 Cyclosporin-containing microemulsion preconcentrate composition  
The present invention relates to a microemulsion preconcentrate composition comprising (1) cyclosporin as an active component; (2) alkyl ester of polycarboxylic acid and/or carboxylic acid ester of...
6063401 Plantago major and hypericum perforatum compound for use in treating a tobacco or nicotine habit  
A composition containing the herbs Plantago major and Hypericum perforatum is presented. Use of the composition, of the present invention, in a form adapted to be orally ingested produces a...
6060084 Method for preparing a core material containment system and the core material containment system prepared thereby  
A method for preparing a core material containment system which prevents or controls leaching of the core material from the containment system, said method comprising the steps of: (1) providing a...
6056971 Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same  
A method for enhancing the dissolution properties of relatively insoluble dietary supplements is provided in accordance with the invention. The method includes the steps of providing at least one...
6045825 Plantago major and Piper methysticum compound for use in treating a tobacco or nicotine habit  
A composition containing the herbs Plantago major and Piper methysticum is presented. Use of the composition, of the present invention, in a form adapted to be orally ingested produces a diminished...
6039958 Stabilized live vaccine  
A stabilized live vaccine containing a varicella virus and a stabilizer, wherein the vaccine is substantially free of Ca 2 + ions and Mg 2 + ions is described. This stabilized live vaccine is...
6039979 Multiparticulate pharmaceutical form with programmed and pulsed release and process for its preparation  
The invention relates to a multiparticulate pharmaceutical form with delayed and pulsed release, enabling to obtain the onset of the availability of the active ingredient within 4 to 8 hours after...
6030642 Extended release clonidine formulation (capsule)  
A method of providing a patient needing clonidine with an extended dosage of clonidine over a prolonged period of time. Such method involves administering to the patient an oral dosage unit...
6030641 Sustained release capsule and method for preparing the same  
A sustained release capsule in which an outer surface of a hard capsule mainly composed of gelatin and containing a physiologically active substance is uniformly covered with a film material...
6027746 Chewable soft gelatin-encapsulated pharmaceutical adsorbates  
The present invention relates to novel liquid oral suspensions incorporated within a soft gelatin capsule comprised of a bitter or bad-tasting pharmaceutical active (such as antihistamines,...
6027748 Pharmaceutical tablet, completely coated, for controlled release of active principles that present problems of bio-availability linked to gastro-intestinal absorption  
Described herein is a particular type of pharmaceutical tablet, for oral use, which is formed by one or more layers, and is specifically designed for controlled release of active principles that...
6024980 Multiphase soft gelatin dosage form  
The present invention relates to a dosage form containing a common enclosure of polymeric material. The enclosure contains multiple phases of semi-solid fill materials containing active ingredients.
6022562 Medicinal and/or nutritional microcapsules for oral administration  
The present invention relates to microcapsules for the oral administration of medicinal and/or nutritional active principles (AP), which are smaller than or equal to 1000 μm in size. These...
6018033 Hydrophilic, hydrophobic, and thermoreversible saccharide gels and forms, and methods for producing same  
Polymerizable saccharide monomers are made by the reaction of a saccharose and a (meth)acrylate. Hydrophilic, hydrophobic and thermoreversible gels and foams are formed upon polymerization of the...
6004558 Methods for treating cancer with legume plant extracts  
The present invention relates to the preparation of therapeutic compositions comprising extracts of leguminous plants from which the isoflavones genistein, daidzein, formononetin and biochanin...
6004580 Pharmaceutical compositions derived from microemulsion-based gels  
A pharmaceutical composition containing a microemulsion made up of a hydrophilic component, a lipophilic component, a surfactant and a drug, where the hydrophilic component, the lipophilic...
6001384 Method for fighting against myiasis affecting cattle and sheep populations and compositions for implementing same  
Process for controlling myiasis in cattle and sheep livestock and compositions for carrying out this process. Composition for topical or parenteral use for controlling myiasis in cattle and sheep,...
5993853 Dietary supplement  
A dietary supplement comprising a reaction product of sodium bicarbonate and apple cider vinegar which is lyophilized.
5989583 Solid lipid compositions of lipophilic compounds for enhanced oral bioavailability  
Lipophilic substances of poor oral bioavailability are mixed with at least one solid fat and phospholipid to obtain a dried solid composition suitable as an oral dosage form. The solid lipid...
5989578 Associations of active principles containing clopidogrel and an antithrombotic agent  
The invention relates to a pharmaceutical composition containing an association of active principles, wherein the active principles are clopidogrel and aspirin, each constituent being present in a...
5989557 Process for extracting polyphenol fractions of tea and compositions produced therewith  
The present invention relates to the preparation of novel polyphenol fractions of Camellia sinensis (tea), the use thereof and formulations containing them. The invention relates specifically to...
5976577 Process for preparing fast dispersing solid oral dosage form  
Process is provided for preparing an oral solid rapidly disintegrating freeze-dried dosage form of a pharmaceutically active substance having an unacceptable taste, wherein prior to freeze drying,...
5968550 Liquisolid systems and methods of preparing same  
Liquisolid systems are acceptably flowing and compressible powdered forms of liquid medications. According to the concept of liquisolid systems, liquid lipophilic drugs, or water-insoluble solid...
5968552 Diltiazem hydrochloride formulation  
The invention relates to a pharmaceutical formulation comprising diltiazem hydrochloride. The formulation is in the form of a mixture of beads blended so as to provide a dissolution profile that...
5965161 Extruded multi-particulates  
A unit dose sustained-release oral dosage form containing a plurality of melt-extruded particles, each consisting essentially of a therapeutically active agent, one or more retardants, and an...
5958452 Extruded orally administrable opioid formulations  
Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.
5958450 Method of drug delivery and coated oral dosage forms for use in the method  
A coating for a drug wherein said coating is formed from seaweed and/or kelp, the seaweed and/or kelp being of a type which is impervious to gastric acidity but denaturable by alkali found in the...
5958451 Process for producing porous, controlled-release capsules and encapsulated composition  
The porous capslues were prepared by mechanical drilling, addition of effervescent to gelatin solution, or purging of inert gas into the gelatin solution. The porous capsules were then hardened by...
5958429 Potentiation of serotonin response  
The availability of serotonin, norepinephrine and dopamine in the brain is increased by administering a serotonin reuptake inhibitor with a serotonin 1A antagonist and L-tryptophan or...